Compounds > losartan

losartan and iloprost

losartan has been researched along with iloprost in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (71.43)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Meanwell, NA	1
Lombard, JH; Weber, DS	1
Lazareth, I	1
Fenlon, D; Pope, JE; Shea, B; Thompson, AE; Welch, V	1
Friesema, J; Huang, T; Lombard, JH; Roman, RJ; Yu, M; Zhu, J	1

Reviews

2 review(s) available for losartan and iloprost

Article	Year
[Management of Raynaud's phenomenon]. Annales de dermatologie et de venereologie, 2001, Volume: 128, Issue:4 Topics: Adult; Age Distribution; Calcium Channel Blockers; Female; Humans; Iloprost; Losartan; Male; Middle Aged; Necrosis; Prognosis; Raynaud Disease; Risk Factors; Sex Distribution; Smoking; Vasodilator Agents; Verapamil	2001
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Arthritis and rheumatism, 2001, Volume: 44, Issue:8 Topics: Calcium Channel Blockers; Cross-Over Studies; Humans; Iloprost; Injections, Intravenous; Ischemia; Losartan; Randomized Controlled Trials as Topic; Raynaud Disease; Scleroderma, Systemic; Skin Temperature; Skin Ulcer	2001

Other Studies

5 other study(ies) available for losartan and iloprost

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Synopsis of some recent tactical application of bioisosteres in drug design. Journal of medicinal chemistry, 2011, Apr-28, Volume: 54, Issue:8 Topics: Cytochrome P-450 Enzyme System; Drug Design	2011
Angiotensin II AT1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries. American journal of physiology. Heart and circulatory physiology, 2001, Volume: 280, Issue:5 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure Determination; Consciousness; Iloprost; Imidazoles; In Vitro Techniques; Losartan; Male; Microcirculation; Muscle, Skeletal; Muscle, Smooth, Vascular; Oxygen; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Sodium, Dietary; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2001
Salt-induced ANG II suppression impairs the response of cerebral artery smooth muscle cells to prostacyclin. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:2 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Cerebral Arteries; Epoprostenol; Hypertension; Iloprost; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Serotonin; Sodium Chloride; Vasodilation; Vasodilator Agents	2005